These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38748391)

  • 1. Managing the Patient with Psoriasis and Metabolic Comorbidities.
    Bellinato F; Maurelli M; Geat D; Girolomoni G; Gisondi P
    Am J Clin Dermatol; 2024 Jul; 25(4):527-540. PubMed ID: 38748391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
    Phan C; Sigal ML; Lhafa M; Barthélémy H; Maccari F; Estève E; Reguiai Z; Perrot JL; Chaby G; Maillard H; Bégon E; Alexandre M; Toussaint P; Bastien-Jacquin M; Bravard P; Sauque E; de Quatrebarbes J; Pfister P; Beauchet A; Mahé E;
    Ann Dermatol Venereol; 2016 Apr; 143(4):264-74. PubMed ID: 26969480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and Nonalcoholic Fatty Liver Disease.
    Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
    Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.
    Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H
    JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis comorbidities: complications and benefits of immunobiological treatment.
    Carvalho AV; Romiti R; Souza CD; Paschoal RS; Milman LM; Meneghello LP
    An Bras Dermatol; 2016; 91(6):781-789. PubMed ID: 28099601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis.
    Valenzuela F; De La Cruz C; Lecaros C; Fernández J; Hevia G; Maul LV; Thyssen JP; Vera-Kellet C; Egeberg A; Armijo D; Pizarro C; Riveros T; Correa H; Guglielmetti A; Didaskalu JA; Wu JJ; Griffiths CEM; Romiti R; Maul JT
    Clin Exp Dermatol; 2022 Dec; 47(12):2234-2241. PubMed ID: 35988043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and comorbid diseases: Implications for management.
    Takeshita J; Grewal S; Langan SM; Mehta NN; Ogdie A; Van Voorhees AS; Gelfand JM
    J Am Acad Dermatol; 2017 Mar; 76(3):393-403. PubMed ID: 28212760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing comorbidities in psoriatic disease.
    Patel P; Rosen CF; Chandran V; Ye YJ; Gladman DD
    Rheumatol Int; 2018 Feb; 38(2):219-227. PubMed ID: 29185085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).
    Kimball AB; Leonardi C; Stahle M; Gulliver W; Chevrier M; Fakharzadeh S; Goyal K; Calabro S; Langholff W; Menter A;
    Br J Dermatol; 2014 Jul; 171(1):137-47. PubMed ID: 24684204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X; Su L; Gao Y; Ding Y
    PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psoriasis comorbidities].
    Gkalpakiotis S
    Cas Lek Cesk; 2017; 156(3):119-122. PubMed ID: 28722453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.